Am J Transplant, Volume 19, Suppl 3 Archives - Page 78 of 214 - ATC Abstracts

2019 American Transplant Congress
Simulation vs. Reality: 250NM as First Unit of Lung Allocation
M. Skeans¹, J. Pyke¹, C. Lehr², R. Lehman³, K. Uccellini³, K. M. Chan⁴, E. D. Lease⁵, R. Daly⁶, M. Valapour²
¹SRTR, Minneapolis, MN, ²Cleveland Clinic Foundation, Cleveland, OH, ³OPTN, Richmond, VA, ⁴Univ. of Michigan, Ann Arbor, MI, ⁵Univ. of WA, Seattle, WA, ⁶Mayo Clinic, Rochester, MN
*Purpose: In November 2017, the OPTN Executive Committee removed donation service area as the first unit of donor allocation, replacing it with a circle of…
2019 American Transplant Congress
Minimally Invasive Kidney Transplantation Using a Novel Intraoperative Cryogenic Circulatory Cooling Device
H. Dai, L. Peng, L. Song, Z. Tang, N. Wu, C. Fang, M. Nie, T. Li, Y. Zheng, X. Xie, S. Yu
Department of Urological Organ Transplantation,The Second Xiangya Hospital of Central South University, Changsha, China
*Purpose: Minimally invasive kidney transplantation (MIKT) has recently been introduced, however, an effective but inexpensive method to balance a minimal incision and reduced ischemia injury…
2019 American Transplant Congress
Listening to the Patients Voice for Developing Transplant Education
S. Brown, H. Li, D. Tsapepas
Renal Transplant, Columbia University Medical Center, New York, NY
*Purpose: Successful outcomes following transplantation (Tx) require a thorough understanding of the Tx process, a close partnership between the patient and transplant center, and life-long…
2019 American Transplant Congress
Kidney & Pancreas Transplant Waitlist Management – A Tiered System Approach
H. L. Busch
Transplant, UCI Health, Orange, CA
*Purpose: Developed and implemented an innovative kidney & pancreas transplant waitlist management system in order to more effectively and efficiently re-evaluate patients on a transplant…
2019 American Transplant Congress
The Effect of Intravenous Immunoglobulin on Human Complement-Dependent Cytotoxicity of Pig Cells: Benefit? Or Harm?
T. Yamamoto¹, Q. Li¹, A. Banks¹, H. Iwase¹, D. Ayares², D. K. Cooper¹, H. Hara¹
¹Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, ²Revivicor, Blacksburg, VA
*Purpose: Xenoreactive antibodies and complement play an important role in pig xenograft rejection. Intravenous immunoglobulin (IVIG) is widely used in desensitization protocols and for the…
2019 American Transplant Congress
Incidence of De Novo Donor Specific Antibodies and Treatment Response for AMR in Pediatric Kidney Transplant Recipients
S. Gattis¹, R. Liverman¹, A. Serluco¹, J. Yin¹, H. C. Sullivan², R. A. Bray³, H. M. Gebel³, S. Jernigan⁴, R. George⁴, P. D. Winterberg⁴, R. Garro⁴
¹Children's Healthcare of Atlanta, Atlanta, GA, ²Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, ³Emory University Hospital, Atlanta, GA, ⁴Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
*Purpose: Antibody-mediated rejection (AMR) is a significant complication in renal transplant patients. The aim of this study was to evaluate the incidence of de novo…
2019 American Transplant Congress
Long Term Impact of Intraoperative Autologous Blood Transfusion on HCC Recurrence in Liver Transplantation
G. Kelly¹, J. L. Pasko¹, E. Dewey², E. Maynard¹, S. L. Orloff¹, C. Enestvedt¹
¹Division of Abdominal Transplant, OHSU, Portland, OR, ²Department of General Surgery, OHSU, Portland, OR
*Purpose: The aim of this study was to determine whether intraoperative autologous transfusion in liver transplant patients with HCC affects the rate of recurrence.*Methods: We…
2019 American Transplant Congress
Discovery and Validation of Blood Genomic Signatures of Acute Rejection in Liver Transplant Recipients
J. Levitsky¹, N. Bridges², J. Odim², M. Brown², D. Ikle³, B. Armstrong³, A. Demetris⁴, S. Asrani⁵, G. Klintmalm⁵, T. Schiano⁶, A. Moss⁷, K. Chavin⁸, C. Miller⁹, M. Kandpal¹⁰, L. Zhao¹⁰, S. Kurian¹¹, M. Abecassis¹⁰
¹Div of Gastroenterology & Comprehensive Tx Cnt, Chicago, IL, ²NIAID, Bethesda, MD, ³Rho, Chapel Hill, NC, ⁴UPMC, Pittsburgh, PA, ⁵Baylor, Dallas, TX, ⁶Mount Sinai, New York, NY, ⁷Mayo Arizona, Phoenix, AZ, ⁸Case Western, Cleveland, OH, ⁹Cleveland Clinic, Cleveland, OH, ¹⁰Comprehensive Transplant Center, Chicago, IL, ¹¹Scripps, San Diego, CA
*Purpose: Biomarker profiles diagnostic of acute rejection (AR) could enhance the management of liver transplant (LT) recipients. Our aim was to discover and validate blood…
2019 American Transplant Congress
A Regulatory T Cell-Intrinsic Role for Ikaros in Acquired Transplant Tolerance
R. M. Thomas, L. Wang, W. W. Hancock, A. D. Wells
The Children's Hospital of Philadelphia, Philadelphia, PA
*Purpose: Ikaros is a transcriptional repressor encoded by the Ikzf1 gene that was recently identified as the pharmacologic target of thalidomide analogs in successful therapy…
2019 American Transplant Congress
Early T Cell Infiltration is Modulated by PD-1/PD-L1 Interactions in Kidney Graft
Y. Shim, R. Fan, N. Dvorina, W. Baldwin
Inflammation and Immunity, Lerner Research Institute, Cleveland, OH
*Purpose: Allogeneic transplants elicit dynamic T cell responses that are modulated by positive and negative co-stimulatory receptors. We have investigated the impact of PD-1, a…